Condensed Statements of Operations (USD $)	3 Months Ended
	Oct. 31, 2012	Oct. 31, 2011
Revenues:
Technical development fees		$ 140,000
OptiChem revenue	2,529	12,008
License fees		50,000
Grant revenue	5,775
Total revenues	8,304	202,008
Costs and expenses:
Research and development	564,224	104,162
General and administrative	754,099	458,983
Amortization	25,327	64,087
Marketing and sales	6,116	4,170
Depreciation	1,807	515
Other expense, impairment of intangibles	333,487
Total costs and expenses	1,685,060	631,917
Loss from operations	(1,676,756)	(429,909)
Other (expense) income:
Interest and dividend income	1,147	4,003
Unrealized holding gain (loss) on investments	10,556	(4,368)
Total other income	11,703	(365)
Net loss	$ (1,665,053)	$ (430,274)
Net loss per share:
Basic and diluted net loss per share	$ (0.07)	$ (0.04)
Weighted average shares outstanding	25,261,609	11,103,367